Last reviewed · How we verify

NCT05624047

The Effect of Breastfeeding Education Via Hybrid Simulation Method in the Antenatal Period on Postpartum Breastfeeding

Completed NA Last updated 15 August 2023
What this trial tests

NA trial testing Breastfeeding education using hybrid simulation method in Breastfeeding in 66 participants. Completed in 12 August 2023.

Timeline
1 December 2022
Primary endpoint
12 August 2023
12 August 2023

Quick facts

Lead sponsorBitlis Eren University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment66
Start date1 December 2022
Primary completion12 August 2023
Estimated completion12 August 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bitlis Eren University

Who can join

Adults 18 to 49, female only, with Breastfeeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to determine the effect of breastfeeding education given to pregnant women by a hybrid simulation method in the antenatal period on postpartum breastfeeding. This study will be carried out in a family health center in Turkey. Breastfeeding education will be given to pregnant women using a hybrid simulation method consisting of a wearable breast model and the standard patient in the intervention group. Women in the control group will receive only routine breastfeeding education.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breastfeeding

Currently open trials in the same condition.

Other Bitlis Eren University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05624047.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing